Lido Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Lido Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,621	Closed	-$6.65K	–	1454
2023 Q3	$6.65K	Buy	+24,621	New	+$8.95K	﹤0.01%	1201

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Lido Advisors's ASXC Position: Q4 2023 in Review

Lido Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q4 2023, closing a stake of 24,621 shares — an estimated $6.65K sold.

Lido Advisors first reported a position in ASXC in Q3 2023 and held it in 1 quarter. The position peaked at $6.65K in Q3 2023. 73 funds tracked by Wall St. Rank hold ASXC as of Q4 2023.

Lido Advisors reported no remaining Asensus Surgical, Inc. position as of Q4 2023 after selling out during the quarter.
Lido Advisors sold 24,621 Asensus Surgical, Inc. shares in Q4 2023, an estimated $6.65K.
Lido Advisors first reported a position in Asensus Surgical, Inc. in Q3 2023 and held it in 1 quarter.
Lido Advisors's Asensus Surgical, Inc. position peaked at $6.65K in Q3 2023.
73 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2023.

Based on Lido Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.